Frank Rimerman Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Frank Rimerman Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.1M	Sell	4,190 -273	-6%	-$131K	0.12%	143
2026 Q1	$2.19M	Sell	4,463 -334	-7%	-$181K	0.14%	114
2025 Q4	$2.78M	Buy	4,797 +53	+1%	+$30K	0.18%	96
2025 Q3	$2.3M	Buy	4,744 +88	+2%	+$41K	0.15%	108
2025 Q2	$1.89M	Sell	4,656 -269	-5%	-$112K	0.13%	125
2025 Q1	$2.45M	Buy	4,925 +104	+2%	+$56.3K	0.19%	88
2024 Q4	$2.51M	Buy	4,821 +140	+3%	+$77K	0.18%	85
2024 Q3	$2.9M	Buy	4,681 +83	+2%	+$49.1K	0.21%	80
2024 Q2	$2.54M	Buy	4,598 +4,574	+19,058%	+$2.62M	0.18%	92
2024 Q1	$13.9K	Hold	24	–	–	﹤0.01%	164
2023 Q4	$12.7K	Buy	+24	New	+$11.6K	﹤0.01%	162
2022 Q2	–	Sell	-1,845	Closed	-$1.09M	–	125
2022 Q1	$1.09M	Hold	1,845	–	–	0.35%	38
2021 Q4	$1.23M	Buy	1,845 +247	+15%	+$154K	0.41%	36
2021 Q3	$913K	Buy	+1,598	New	+$877K	0.35%	39

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Frank Rimerman Advisors's TMO Position: Q2 2026 in Review

Frank Rimerman Advisors reduced its Thermo Fisher Scientific (TMO) stake by 6.1% in Q2 2026, selling an estimated $131K and leaving 4,190 shares worth $2.1M. The position accounts for 0.12% of the portfolio, ranked #143.

Frank Rimerman Advisors first reported a position in TMO in Q3 2021 and has held it in 14 quarters since. The position peaked at $2.9M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Frank Rimerman Advisors held 4,190 shares of Thermo Fisher Scientific worth $2.1M as of Q2 2026.
Frank Rimerman Advisors sold 273 Thermo Fisher Scientific shares in Q2 2026, an estimated $131K.
Thermo Fisher Scientific made up 0.12% of Frank Rimerman Advisors's portfolio in Q2 2026, its #143 holding.
Frank Rimerman Advisors first reported a position in Thermo Fisher Scientific in Q3 2021 and has held it in 14 quarters since.
Frank Rimerman Advisors's Thermo Fisher Scientific position peaked at $2.9M in Q3 2024.
2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Frank Rimerman Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.